St Germain D J CO Inc Novo Nordisk A S Transaction History

St Germain D J CO Inc

  • $2.12 Billion
  • Q3 2024

A detailed history of St Germain D J CO Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, St Germain D J CO Inc holds 80,857 shares of NVO stock, worth $8.23 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
80,857
Previous 82,839 2.39%
Holding current value
$8.23 Million
Previous $11.8 Million 18.58%
% of portfolio
0.45%
Previous 0.58%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
SELL
$119.07 - $145.42 $235,996 - $288,222
-1,982 Reduced 2.39%
80,857 $9.63 Million
Q2 2024

Jul 08, 2024
SELL
$122.71 - $146.91 $197,440 - $236,378
-1,609 Reduced 1.91%
82,839 $11.8 Million
Q1 2024

Apr 02, 2024
SELL
$102.11 - $135.92 $173,484 - $230,928
-1,699 Reduced 1.97%
84,448 $10.8 Million
Q4 2023

Jan 02, 2024
SELL
$87.78 - $105.45 $117,010 - $140,564
-1,333 Reduced 1.52%
86,147 $8.91 Million
Q3 2023

Oct 23, 2023
SELL
$90.94 - $199.54 $2.68 Million - $5.87 Million
-29,424 Reduced 25.17%
87,480 $7.96 Million
Q2 2023

Sep 07, 2023
SELL
$155.98 - $172.65 $2.47 Million - $2.73 Million
-15,826 Reduced 11.92%
116,904 $18.9 Million
Q4 2022

Feb 27, 2023
SELL
$102.55 - $135.33 $357,489 - $471,760
-3,486 Reduced 2.56%
132,730 $18 Million
Q2 2022

Aug 15, 2022
SELL
$103.24 - $121.81 $318,392 - $375,662
-3,084 Reduced 2.21%
136,216 $15.2 Million
Q1 2022

May 12, 2022
SELL
$93.1 - $112.54 $122,798 - $148,440
-1,319 Reduced 0.94%
139,300 $15.5 Million
Q4 2021

Feb 11, 2022
SELL
$95.88 - $117.08 $572,211 - $698,733
-5,968 Reduced 4.07%
140,619 $15.7 Million
Q3 2021

Nov 03, 2021
SELL
$84.42 - $106.62 $571,016 - $721,177
-6,764 Reduced 4.41%
146,587 $14.1 Million
Q2 2021

Jul 28, 2021
SELL
$67.66 - $84.76 $246,147 - $308,356
-3,638 Reduced 2.32%
153,351 $12.8 Million
Q1 2021

May 13, 2021
SELL
$67.06 - $75.82 $84,965 - $96,063
-1,267 Reduced 0.8%
156,989 $10.6 Million
Q4 2020

Feb 04, 2021
SELL
$63.89 - $73.8 $142,474 - $164,574
-2,230 Reduced 1.39%
158,256 $11.1 Million
Q3 2020

Nov 10, 2020
SELL
$63.69 - $70.22 $233,742 - $257,707
-3,670 Reduced 2.24%
160,486 $11.1 Million
Q2 2020

Aug 13, 2020
SELL
$58.54 - $67.94 $372,080 - $431,826
-6,356 Reduced 3.73%
164,156 $10.7 Million
Q1 2020

May 13, 2020
SELL
$49.46 - $64.78 $1.07 Million - $1.4 Million
-21,562 Reduced 11.23%
170,512 $10.3 Million
Q4 2019

Feb 14, 2020
SELL
$49.86 - $58.26 $51,256 - $59,891
-1,028 Reduced 0.53%
192,074 $11.1 Million
Q3 2019

Oct 17, 2019
SELL
$47.54 - $53.43 $36,700 - $41,247
-772 Reduced 0.4%
193,102 $9.98 Million
Q2 2019

Jul 24, 2019
BUY
$46.79 - $52.47 $591,425 - $663,220
12,640 Added 6.97%
193,874 $9.9 Million
Q1 2019

May 02, 2019
SELL
$46.36 - $52.63 $299,346 - $339,831
-6,457 Reduced 3.44%
181,234 $9.48 Million
Q4 2018

Feb 05, 2019
SELL
$41.54 - $47.25 $4,195 - $4,772
-101 Reduced 0.05%
187,691 $8.65 Million
Q3 2018

Oct 23, 2018
BUY
$46.76 - $51.24 $157,581 - $172,678
3,370 Added 1.83%
187,792 $8.85 Million
Q2 2018

Aug 07, 2018
SELL
$44.29 - $50.42 $384,658 - $437,897
-8,685 Reduced 4.5%
184,422 $8.51 Million
Q1 2018

Apr 20, 2018
SELL
$48.49 - $58.14 $3,733 - $4,476
-77 Reduced 0.04%
193,107 $9.51 Million
Q4 2017

Feb 13, 2018
SELL
$47.53 - $53.73 $24,002 - $27,133
-505 Reduced 0.26%
193,184 $10.4 Million
Q3 2017

Oct 31, 2017
BUY
$41.15 - $49.22 $7.97 Million - $9.53 Million
193,689
193,689 $9.33 Million

Others Institutions Holding NVO

# of Institutions
1,953
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track St Germain D J CO Inc Portfolio

Follow St Germain D J CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of St Germain D J CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on St Germain D J CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email